BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27861809)

  • 1. Immune monitoring in renal transplantation: The search for biomarkers.
    Danger R; Sawitzki B; Brouard S
    Eur J Immunol; 2016 Dec; 46(12):2695-2704. PubMed ID: 27861809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biomarkers of kidney transplant rejection, an endless search?
    Jacquemont L; Soulillou JP; Degauque N
    Expert Rev Mol Diagn; 2017 Jul; 17(7):687-697. PubMed ID: 28571481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
    Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in renal transplantation.
    Bestard O; Cruzado JM; la Franquesa M; Grinyó JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):467-73. PubMed ID: 20613522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    Sarwal MM
    Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an immune function assay to monitor immunosuppression.
    Grimm P
    Pediatr Transplant; 2006 Aug; 10(5):533-5. PubMed ID: 16856988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological Markers in Organ Transplantation].
    Beckmann JH; Heits N; Braun F; Becker T
    Zentralbl Chir; 2017 Apr; 142(2):161-168. PubMed ID: 23696203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we use biomarkers and functional assays to implement personalized therapies in transplantation?
    Sawitzki B; Pascher A; Babel N; Reinke P; Volk HD
    Transplantation; 2009 Jun; 87(11):1595-601. PubMed ID: 19502949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring the operationally tolerant liver allograft recipient.
    Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
    Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of novel diagnostics to individualize immunosuppression following transplantation.
    Schlickeiser S; Boës D; Streitz M; Sawitzki B
    Transpl Int; 2015 Aug; 28(8):911-20. PubMed ID: 25611562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantation.
    Ashton-Chess J; Giral M; Soulillou JP; Brouard S
    Transplantation; 2009 May; 87(9 Suppl):S95-9. PubMed ID: 19424020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.
    Vollmers C; De Vlaminck I; Valantine HA; Penland L; Luikart H; Strehl C; Cohen G; Khush KK; Quake SR
    PLoS Med; 2015 Oct; 12(10):e1001890. PubMed ID: 26466143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characteristics of renal transplant tolerance in humans.
    Lu J; Zhang X
    Mol Immunol; 2016 Sep; 77():71-8. PubMed ID: 27479171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance assays: measuring the unknown.
    Newell KA; Larsen CP
    Transplantation; 2006 Jun; 81(11):1503-9. PubMed ID: 16770237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of rejection and tolerance: lessons from clinical research.
    Viklicky O; Hribova P; Brabcova I
    Nephrol Dial Transplant; 2013 Nov; 28(11):2701-8. PubMed ID: 23739154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers and Pharmacogenomics in Kidney Transplantation.
    Crowley LE; Mekki M; Chand S
    Mol Diagn Ther; 2018 Oct; 22(5):537-550. PubMed ID: 29971647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.